Clinical Guide to Transplantation in Lymphoma

This new book provides cutting edge information for transplantation in lymphoma from a clinical perspective. With 26 chapters and over 50 international contributors this title offers a single reference for physicians on how to integrate, transplantation and novel therapies in patients with lymphoid malignancies.

 

Section one provides an overview of transplantation in lymphoma, including the historical perspective, role of lymphoma working committees, current use of transplantation in children and adults, the variety of conditioning regimens for auto and allo–HSCT, pre–transplant evaluation, stem cell mobilizations, donor search for patients needing allo–HSCT, and management of long term complications after HSCT for lymphomas. Section two covers management of the lymphoid malignancies, focusing on standard of care transplant management, timing and preparing patients for transplantation, management of post– transplant relapses and most importantly discussion on novel therapies and their integration in transplantation for lymphomas.

 

The appendices provide a quick reference checklist on follow–up after autologous and allogenic stem cell transplantation in lymphoma.

 

Provides practical management guidance on how to integrate, transplantation and novel therapies in patients with lymphoid malignancies Covers an overview of transplantation in lymphoma, and management of the lymphoid malignancies Discusses organizational aspects of transplant patients and managing a transplant program Appendices provide handy quick–reference information on follow–up after autologous and allogenic stem cell transplantation in lymphoma

 

This title is of use for transplant clinicians, oncologists, and haematologists.

Bipin N Savani, MD
Professor of Medicine
Director, Long Term Transplant Clinic
Division of Hematology/Oncology
Vanderbilt Ingram Cancer Center
Vanderbilt University Medical Center
Nashville, TN, USA

Dr Savani s area of specialization is in the treatment of hematological malignancies and stem cell transplantation, and his primary field of research is in the long–term follow–up after transplantation, including regimen–related toxicity/ supportive care, and outcomes analysis of transplant recipients. Dr Savani has published over 175 peer reviewed articles, reviews, book chapters, editorials, perspectives and commentaries in the field of hematological malignances and stem cell transplantation. He is Associate Editor of the journal Bone Marrow Transplantation (official journal of the European Group for Blood and Marrow Transplantation– EBMT) and serves as an editorial advisory board member for several journals including Biology of Blood and Marrow Transplantation (official journal of the American Society of Blood and Marrow Transplantation. Dr Savani is currently Co–Chair of the steering committee on clinical practice guidelines and former vice–chair of the committee on evidence–based reviews for the American Society of Blood and Marrow Transplantation (ASBMT). He also serves as Co–Chair for the Late Effects & Quality of Life Working Committee (LEWC) and Advisory Committee Members at Large North America, Center for International Blood and Marrow Transplant research (CIBMTR).

Mohamad Mohty, MD, PhD
Professor
Head, Clinical Hematology and cellular therapy department
Université Pierre & Marie Curie
Hospital Saint Antoine
INSERM, U938
Paris, France

Mohamad Mohty is Professor of Hematology and head of the Hematology and cellular therapy Department at the Saint–Antoine Hospital and University Pierre & Marie Curie (Paris, France). Professor Mohty obtained his medical degree from the University of Montpellier, France, and his PhD from the University of Marseille, France. Before moving to Paris, he was head of the Transplant Program at the University–Hospital of Nantes, France. He also undertook post–doctoral work at the Hematology Department, Imperial College, Hammersmith Hospital, London, UK. Professor Mohty s is also currently head of a translational research team (INSERM team N°7) at the Saint–Antoine Research centre in Paris and his research is focused on the pathophysiology of graft–vs–host disease and the immunobiology of normal and pathological antigen–presenting cells, especially the impact of novel immunomodulatory agents such as IMiDs and hypomethylating agents. He has a special clinical focus on the development of reduced–toxicity conditioning regimens, immunotherapy and different aspects of therapy of leukemia and multiple myeloma.

Professor Mohty is president of the European Group for Blood and Marrow Transplantation (EBMT). He serves on the board of the EBMT, and the Intergroupe Francophone du Myelome (IFM). He is a member of the American Society of Hematology, American Society for Clinical Oncology, American Society for Blood and Marrow Transplantation, European Hematology Association, International Society for Experimental Hematology, and EBMT.

Professor Mohty has published more than 280 peer–reviewed articles in the field of stem cell transplantation, leukemia and myeloma, in different hematology and immunology journals. He serves as an Editor–in–Chief for Bone marrow Transplantation and Associate Editor for Leukemia, European Journal of Haematology and Blood Cancer Journal, as a member of the editorial board of Haematologica, and as a regular reviewer in different immunology, hematology, and cancer journals such as Blood and The Lancet.